Skip to content

Clinical trials

Completed Phase 1 Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 1 Status: Completed Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20041
20051
20064
20078
20086
20092
20102
20111
20125
20135
20142
20174
20182
20201
20211
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline19
AstraZeneca4
National Heart, Lung, and Blood Institute (NHLBI)4
MedImmune LLC3
Bristol-Myers Squibb2
Washington University School of Medicine2
Bayer1
Codman & Shurtleff1
Dong-A ST Co., Ltd.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis55
Cardiovascular Diseases7
Inflammation5
Peripheral Arterial Disease5
Diabetes Mellitus, Type 23
Hypercholesterolemia3
Intermittent Claudication3
Carotid Artery Diseases2
Carotid Stenosis2
Coronary Artery Disease2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.